شیمی دارویی داروپخش
دشیمی | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 38,950 2.99
Close Price: 38,970
Income Statement
AGM
Interim
2026/07/07 Fiscal Year 2026/03/2012 Month | 2025/05/19 Fiscal Year 2025/03/2012 Month | 2024/05/18 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 11.621 Trillion | 9.601 Trillion | 14.06 Trillion | |
Total Revenues | 11.621 Trillion | 9.601 Trillion | 14.06 Trillion | |
Cost of Goods Sold | 7.821 Trillion | 7.165 Trillion | 8.654 Trillion | |
Gross Profit | 3.8 Trillion | 2.436 Trillion | 5.406 Trillion | |
General & Administrative Expenses | 489.32 Billion | 482.05 Billion | 296.888 Billion | |
Net Operating Income & Expenses | -441.459 Billion | -543.101 Billion | 55.228 Billion | |
Operating Profit (Loss) | 2.869 Trillion | 1.411 Trillion | 5.164 Trillion | |
Profit Before Tax | 2.1 Trillion | 994.293 Billion | 4.867 Trillion | |
Tax | 234.221 Billion | 172.322 Billion | 1.087 Trillion | |
Net Profit (Loss) After Tax | 1.866 Trillion | 821.971 Billion | 3.78 Trillion | |
Retained Earnings at Beginning of Period | 2.207 Trillion | 4.041 Trillion | 3.048 Trillion | |
Approved Dividends — Prior Year AGM | -859.5 Billion | -2.655 Trillion | -2.743 Trillion | |
Allocable Profit | 3.214 Trillion | 2.207 Trillion | 4.085 Trillion | |
Legal Reserve | - | - | 44.5 Billion | |
Approved Dividends — Current Year | 900 Billion | 859.5 Billion | 2.655 Trillion | |
Retained Earnings at End of Period | 2.314 Trillion | 1.348 Trillion | 1.386 Trillion |